Literature DB >> 7974491

Specificity and properties of propofol as an antioxidant free radical scavenger.

T R Green1, S R Bennett, V M Nelson.   

Abstract

The active component of the anesthetic propofol (2,6-diisopropylphenol), which structurally resembles butylated hydroxy-toluene (BHT), a known free radical scavenger, was examined and compared to BHT with regard to its dose-dependent radical scavenging activity. Studies on the ameliorating effect of propofol in inhibiting radical production revealed that it preferentially scavenges organoradical species. In aqueous suspension it is more efficient than BHT as a free radical scavenger of riboflavin radicals and in blocking formation of malondialdehyde degradation products generated from lipid hydroperoxides of arachidonic acid. Neither propofol nor BHT showed any radical scavenging activities at concentration ranges less than 10 micrograms/ml. Propofol quenched radicals generated by photoillumination of riboflavin by 50% at 30 micrograms/ml. Under the same conditions BHT still showed no radical scavenging activity. At 50 micrograms/ml propofol the formation of malondialdehyde degradation products of arachidonic acid formed by illuminating arachidonic acid in test mixtures containing riboflavin was decreased by 38% compared to a decrease of only 24% with BHT substituted in place of propofol. The concentration of propofol required to ameliorate free radicals is approximately an order of magnitude higher than therapeutic doses of propofol used in anesthesia, suggesting that its scavenging activity during anesthesia is likely very limited.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7974491     DOI: 10.1006/taap.1994.1240

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  24 in total

1.  [Effect of propofol on apoptosis of PC12 cells under hypoxic condition and the mechanism].

Authors:  Mang Sun; Lian-Ju Shen; Yang Liu; Qing Yu; Chun-Lan Long; Shang-Ying-Ying Li; Sheng-Fen Tu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  The protective effect of propofol on erythrocytes during cardiopulmonary bypass.

Authors:  S Zhang; S Yao
Journal:  J Tongji Med Univ       Date:  2001

3.  Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery.

Authors:  A D Manataki; A D Tselepis; G K Glantzounis; H M Arnaoutoglou; E C Tsimoyiannis; N E Stavropoulos
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

4.  Potent antioxidative potential of propofol during cardiopulmonary bypass in the adult.

Authors:  S Zhang; S Yao
Journal:  J Tongji Med Univ       Date:  2001

5.  The protective effect of propofol on erythrocytes during cardiopulmonary bypass.

Authors:  Shihai Zhang; Shanglong Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Early administration of propofol protects against endotoxin-induced acute lung injury in rats by inhibiting the TGF-beta1-Smad2 dependent pathway.

Authors:  Ju Gao; Wei-Xian Zhao; Fu-Shan Xue; Luo-Jing Zhou; Shao-qun Xu; Ning Ding
Journal:  Inflamm Res       Date:  2009-11-27       Impact factor: 4.575

7.  Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion.

Authors:  Nicola King; Madj Al Shaama; M-Saadeh Suleiman
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

Review 8.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

9.  Oleuropein attenuates cognitive dysfunction and oxidative stress induced by some anesthetic drugs in the hippocampal area of rats.

Authors:  Masoud Alirezaei; Maryam Rezaei; Shahin Hajighahramani; Ali Sookhtehzari; Katayoun Kiani
Journal:  J Physiol Sci       Date:  2016-03-29       Impact factor: 2.781

Review 10.  Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.

Authors:  B Fulton; E M Sorkin
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.